|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 46 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2011-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
7,280 |
6,066,729 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2011-06-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(9,590) |
62,407 |
0 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2011-06-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,902) |
0 |
0 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2011-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,902 |
6,669,338 |
0 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2011-06-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,786) |
0 |
0 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2011-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,786 |
5,266,568 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2011-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
9,852 |
1,252,625 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-08-10 |
4 |
B |
$16.12 |
$98,403 |
I/I |
5,934 |
254,763 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-08-23 |
4 |
B |
$16.97 |
$92,814 |
I/I |
5,468 |
1,770,681 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-08-23 |
4 |
B |
$14.60 |
$38,870 |
I/I |
2,629 |
306,078 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-08-23 |
4 |
B |
$14.60 |
$2,528,388 |
I/I |
171,009 |
13,652,467 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-08-23 |
4 |
B |
$16.97 |
$8,538 |
I/I |
503 |
255,266 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-08-24 |
4 |
B |
$14.98 |
$2,202 |
I/I |
147 |
306,225 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-08-24 |
4 |
B |
$14.98 |
$143,432 |
I/I |
9,576 |
13,662,043 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-08-25 |
4 |
B |
$15.35 |
$234,651 |
I/I |
15,150 |
321,375 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-08-25 |
4 |
B |
$15.35 |
$15,253,844 |
I/I |
984,850 |
14,646,893 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-09-06 |
4 |
B |
$17.00 |
$2,206,641 |
I/I |
129,187 |
14,776,080 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2011-09-06 |
4 |
B |
$17.00 |
$30,285 |
I/I |
1,773 |
323,148 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-22 |
4 |
B |
$17.43 |
$43,722 |
I/I |
2,509 |
257,775 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-22 |
4 |
B |
$17.43 |
$162,759 |
I/I |
9,340 |
1,780,021 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-23 |
4 |
B |
$17.58 |
$158,456 |
I/I |
8,933 |
266,708 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-23 |
4 |
B |
$17.58 |
$651,492 |
I/I |
36,728 |
1,816,749 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-26 |
4 |
B |
$18.13 |
$113,962 |
I/I |
6,287 |
272,995 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-26 |
4 |
B |
$18.13 |
$485,450 |
I/I |
26,781 |
1,843,530 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-29 |
4 |
B |
$17.97 |
$593,488 |
I/I |
32,995 |
1,876,525 |
1.5 |
- |
|
1397 Records found
|
|
Page 46 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|